Armistice Capital »

Inuvo shares owned by Armistice Capital

Quarter-by-quarter ownership of Inuvo (INUV) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Inuvo

Tip: Access up to 7 years of quarterly data

All positions including Inuvo held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inuvo by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.0M 1.6M 1.26

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Inuvo

Armistice Capital
Vanguard Capital Management
Perkins Capital Management
Geode Capital Management
BlackRock
Vanguard Fiduciary Trust
Renaissance Technologies
State Street Corporation
Centiva Capital
Citadel Advisors
Jane Street
Hrt Financial
Northern Trust
Bridgeway Capital Management
Susquehanna International

View all funds holding Inuvo